Avadel Pharmaceuticals

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$77,467
$68,129
$52,511
$50,410
Gross Profit
80,468
61,763
46,934
45,598
EBITDA
3,584
9,918
-1,779
-1,593
EBIT
2,469
8,850
-2,604
-2,261
Net Income
20
9,665
-4,920
-5,043
Net Change In Cash
77,467
68,129
52,511
50,410
Free Cash Flow
23,249
12,516
-8,232
7,873
Cash
79,813
63,402
56,370
51,371
Basic Shares
101,276
99,087
96,601
96,395

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$169,117
$27,963
$1,496
$0
Gross Profit
153,840
27,117
-1,493
-815
EBITDA
-35,568
-149,125
-97,604
-82,388
EBIT
-38,249
-150,891
-99,097
-83,203
Net Income
-48,832
-160,276
-137,464
-77,329
Net Change In Cash
169,117
27,963
1,496
0
Cost of Revenue
-20,118
Free Cash Flow
-46,907
-128,511
-71,020
-77,336
Cash
51,371
31,167
73,981
50,708
Basic Shares
95,141
80,174
60,094
58,535

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
$0.0002
2025-06-30
$0.10
2025-03-31
-$0.05